Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study
Therapeutic Advances in Respiratory Disease2023Vol. 17, pp. 17534666231167716–17534666231167716
Citations Over TimeTop 10% of 2023 papers
Mengru Zhang, Alyn H. Morice, Fengli Si, Li Zhang, Qiang Chen, Shengyuan Wang, Yiqing Zhu, Xianghuai Xu, Li Yu, Zhongmin Qiu
Abstract
This is the first report that fully represented a guideline-led treatment protocol for refractory chronic cough (RCC) based on a large series of patients, which evaluated the short- and long-term effects of the currently available treatments for RCC. We found that the therapeutic trial of different neuromodulators is a pragmatic strategy, which helped around two-thirds of patients. Gabapentin, deanxit (flupentixol/melitracen), and baclofen had similar therapeutic outcomes. This study may offer real-world experience for the future management of RCC.
Related Papers
- → Observational Studies(2023)29 cited
- → British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease(2020)37 cited
- → The Effects of Video Observational Training on Video and Live Observational Proficiency(1994)12 cited
- [The guideline for the treatment of mood disorders in USA and Japan].(2001)
- [Verification of guideline for gastric cancer treatment based on a questionnaire].(2004)